{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:26:29Z","timestamp":1790799989011,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jchromb.2020.122038","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T17:28:54Z","timestamp":1582306134000},"page":"122038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Automatic quantification of uracil and dihydrouracil in plasma"],"prefix":"10.1016","volume":"1142","author":[{"given":"Tiphaine","family":"Robin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Saint-Marcoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriane","family":"Toinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na\u00efma","family":"Tafzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souleiman","family":"El Balkhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2020.122038_b0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-198916040-00002","article-title":"Clinical pharmacology of 5-fluorouracil","volume":"16","author":"Diasio","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2020.122038_b0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/179663a0","article-title":"Fluorinated pyrimidines, a new class of tumour-inhibitory compounds","volume":"179","author":"Heidelberger","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.jchromb.2020.122038_b0015","first-page":"CD008398","article-title":"Oral versus intravenous fluoropyrimidines for colorectal cancer","author":"Chionh","year":"2017","journal-title":"Cochrane Database Syst Rev, 7"},{"key":"10.1016\/j.jchromb.2020.122038_b0020","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1158\/0008-5472.CAN-16-0150","article-title":"On Clinical Studies with 5-Fluorouracil","volume":"76","author":"Jordan","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2020.122038_b0025","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.bulcan.2018.06.008","article-title":"5-fluorouracil therapeutic drug monitoring: Update and recommendations of the STP-PT group of the SFPT and the GPCO-Unicancer","volume":"105","author":"Lemaitre","year":"2018","journal-title":"Bull. Cancer"},{"key":"10.1016\/j.jchromb.2020.122038_b0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bulcan.2018.02.001","article-title":"Dihydropyrimidine dehydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: update and recommendations of the French GPCO-Unicancer and RNPGx networks","volume":"105","author":"Loriot","year":"2018","journal-title":"Bull. Cancer"},{"key":"10.1016\/j.jchromb.2020.122038_b0035","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2217\/pgs.13.54","article-title":"Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patients","volume":"14","author":"van Kuilenburg","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jchromb.2020.122038_b0040","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1080\/17425255.2018.1550484","article-title":"How can we best monitor 5-FU administration to maximize benefit to risk ratio?","volume":"14","author":"Goirand","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jchromb.2020.122038_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ctrv.2016.08.002","article-title":"Improving safety of fluoropyrimidine chemotherapy by individualizing treatment based on dihydropyrimidine dehydrogenase activity - Ready for clinical practice?","volume":"50","author":"Meulendijks","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jchromb.2020.122038_b0050","first-page":"224","article-title":"Routine dihydropyrimidine dehydrogenase testing for anticipating 5-fluorouracil-related severe toxicities: hype or hope?","volume":"9","author":"Ciccolini","year":"2010","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.jchromb.2020.122038_b0055","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/bjc.2017.94","article-title":"Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity","volume":"116","author":"Meulendijks","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jchromb.2020.122038_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175998","article-title":"New advances in DPYD genotype and risk of severe toxicity under capecitabine","volume":"12","author":"Etienne-Grimaldi","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jchromb.2020.122038_b0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2006.09.006","article-title":"5-Fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency","volume":"249","author":"Boisdron-Celle","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jchromb.2020.122038_b0070","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1200\/JCO.1999.17.4.1105","article-title":"Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: a potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosage","volume":"17","author":"Gamelin","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jchromb.2020.122038_b0075","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/2212697X04666170817123425","article-title":"Upfront Dpd Deficiency Detection to Secure 5-Fu Administration: Part 2- Application to Head-and-Neck Cancer Patients","volume":"4","author":"Launay","year":"2017","journal-title":"Clin. Cancer Drugs"},{"key":"10.1016\/j.jchromb.2020.122038_b0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/bcp.12790","article-title":"Beating the odds: efficacy and toxicity of dihydropyrimidine dehydrogenase-driven adaptive dosing of 5-FU in patients with digestive cancer","volume":"81","author":"Launay","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2020.122038_b0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0378-4347(97)00211-9","article-title":"Rapid and sensitive high-performance liquid chromatographic analysis of halogenopyrimidines in plasma","volume":"695","author":"Gamelin","year":"1997","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2020.122038_b0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1570-0232(02)00239-8","article-title":"Simple liquid chromatographic method for the determination of uracil and dihydrouracil plasma levels: a potential pretreatment predictor of 5-fluorouracil toxicity","volume":"774","author":"Garg","year":"2002","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2020.122038_b0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2710.2004.00569.x","article-title":"A simple and rapid high-performance liquid chromatographic (HPLC) method for 5-fluorouracil (5-FU) assay in plasma and possible detection of patients with impaired dihydropyrimidine dehydrogenase (DPD) activity","volume":"29","author":"Ciccolini","year":"2004","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jchromb.2020.122038_b0100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jchromb.2005.05.044","article-title":"An accurate dihydrouracil\/uracil determination using improved high performance liquid chromatography method for preventing fluoropyrimidines-related toxicity in clinical practice","volume":"823","author":"Remaud","year":"2005","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2020.122038_b0105","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jchromb.2006.02.046","article-title":"High-performance liquid chromatographic assay with UV detection for measurement of dihydrouracil\/uracil ratio in plasma","volume":"834","author":"Deporte","year":"2006","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2020.122038_b0110","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1177\/147323001003800413","article-title":"The value of dihydrouracil\/uracil plasma ratios in predicting 5-fluorouracil-related toxicity in colorectal cancer patients","volume":"38","author":"Kristensen","year":"2010","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.jchromb.2020.122038_b0115","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.clinbiochem.2015.04.019","article-title":"Improved determination of uracil and dihydrouracil in plasma after a loading oral dose of uracil using high-performance liquid chromatography with photodiode array detection and porous graphitic carbon stationary phase","volume":"48","author":"Hahn","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2020.122038_b0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/cpt.210","article-title":"Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil\/uracil ratio","volume":"99","author":"Thomas","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122038_b0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1570-0232(02)00009-0","article-title":"Measurement of endogenous uracil and dihydrouracil in plasma and urine of normal subjects by liquid chromatography-tandem mass spectrometry","volume":"769","author":"Jiang","year":"2002","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2020.122038_b0130","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1373\/clinchem.2007.102251","article-title":"HPLC with UV or mass spectrometric detection for quantifying endogenous uracil and dihydrouracil in human plasma","volume":"54","author":"Svobaite","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2020.122038_b0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bmc.2741","article-title":"LC-MS\/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients","volume":"27","author":"Buchel","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2020.122038_b0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/FTD.0b013e318240405f","article-title":"A rapid HPLC-ESI-MS\/MS method for determination of dihydrouracil\/uracil ratio in plasma: evaluation of toxicity to 5-flurouracil in patients with gastrointestinal cancer","volume":"34","author":"Cesar","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2020.122038_b0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jpba.2017.04.055","volume":"142","author":"Chavani","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122038_b0150","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/chromsci\/bms085","article-title":"Validation of an ultra-high performance liquid chromatography tandem mass spectrometric method for quantifying uracil and 5,6-dihydrouracil in human plasma","volume":"50","author":"Coudore","year":"2012","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2020.122038_b0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpba.2016.04.039","article-title":"Development and validation of a rapid and sensitive UPLC-MS\/MS method for determination of uracil and dihydrouracil in human plasma","volume":"126","author":"Jacobs","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122038_b0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.chroma.2014.06.065","article-title":"Simultaneous quantification of purine and pyrimidine bases, nucleosides and their degradation products in bovine blood plasma by high performance liquid chromatography tandem mass spectrometry","volume":"1356","author":"Stentoft","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2020.122038_b0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clinbiochem.2010.06.005","article-title":"Progress in automation of LC-MS in laboratory medicine","volume":"44","author":"Vogeser","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2020.122038_b0170","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.4155\/bio.14.161","article-title":"Current advances and strategies towards fully automated sample preparation for regulated LC-MS\/MS bioanalysis","volume":"6","author":"Zheng","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2020.122038_b0175","doi-asserted-by":"crossref","first-page":"41_52","DOI":"10.1016\/j.trac.2016.12.011","article-title":"The dawn of unmanned analytical laboratories","volume":"88","author":"Prabhu","year":"2017","journal-title":"TRAC-Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2020.122038_b0180","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.4155\/bio.15.137","article-title":"Online and automated sample extraction","volume":"7","author":"Wei","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2020.122038_b0185","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1007\/s00216-018-1159-7","article-title":"Fully automated sample preparation procedure to measure drugs of abuse in plasma by liquid chromatography tandem mass spectrometry","volume":"410","author":"Robin","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2020.122038_b0190","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1093\/clinchem\/33.12.2299","article-title":"Stability of 5-fluorouracil in whole blood and plasma","volume":"33","author":"Murphy","year":"1987","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2020.122038_b0195","unstructured":"T.C.O.T.E. COMMUNITIES, implementing Council Directive 96\/23\/EC concerning the performance of analytical methods and the interpretation of results, in: E.u. commission (Ed.), 2002."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023220300088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023220300088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:59:18Z","timestamp":1761605958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023220300088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":39,"alternative-id":["S1570023220300088"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122038","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automatic quantification of uracil and dihydrouracil in plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122038"}}